The Centre must speed up negotiations with foreign companies towards the removal of stumbling blocks to expand coverage
Moderna's vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik
The company has received final approval for its abbreviated new drug application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL from the United States Food and Drug Administration (US FDA), Cipla said
The first batch of Covid positive patients were administered with the antibody cocktail at Yashoda Hospital Secunderabad on Wednesday
The test is a rapid point-of-care nasopharyngeal swab test that directly detects the presence or absence of coronavirus antigen in the patient's body, generating results within 15-20 minutes.
- Advertisement -